Cenobamate showed high effectiveness over 1 year in patients previously tried on 2-6 ASMs, confirming its real-world application.
Patients using cenobamate earlier in their treatment history experienced better outcomes than those who started it later.
This observational analysis highlights cenobamate's well-tolerated profile, supporting its use in diverse treatment lines.
Improved outcomes suggest that timely intervention with cenobamate may enhance management in epilepsy treatment.
Abstract
Cenobamate was effective and well tolerated in patients who had tried 2-6 prior ASMs in a real-world setting. High effectiveness was confirmed at 1 year, with better outcomes in earlier users.